Advertisement
CODX vs MBOT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CODX is a Hold and MBOT is a Hold.
CODX sees MACD Histogram crosses below signal line
CODX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 14, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 40 instances where the indicator turned negative. In 36 of the 40 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CODX as a result. In 72 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
CODX moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CODX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CODX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +14.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where CODX advanced for three days, in 174 of 210 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
CODX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.141) is normal, around the industry mean (4.142). P/E Ratio (-0.010) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.171) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. CODX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CODX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
MBOT's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for MBOT turned positive on October 22, 2026. Looking at past instances where MBOT's MACD turned positive, the stock continued to rise in 43 of 48 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MBOT's RSI Oscillator exited the oversold zone, 24 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on MBOT as a result. In 75 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
Following a +9.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where MBOT advanced for three days, in 150 of 205 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 45 cases where MBOT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MBOT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
MBOT broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MBOT entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. MBOT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.082) is normal, around the industry mean (4.142). P/E Ratio (-4.440) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (263.158) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBOT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CODX | MBOT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 14 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 45 Fair valued | 93 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 97 | |
PRICE GROWTH RATING 1..100 | 98 | 65 | |
P/E GROWTH RATING 1..100 | 6 | 12 | |
SEASONALITY SCORE 1..100 | 10 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CODX's Valuation (45) in the Biotechnology industry is somewhat better than the same rating for MBOT (93). This means that CODX’s stock grew somewhat faster than MBOT’s over the last 12 months.
CODX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MBOT (100). This means that CODX’s stock grew similarly to MBOT’s over the last 12 months.
MBOT's SMR Rating (97) in the Biotechnology industry is in the same range as CODX (99). This means that MBOT’s stock grew similarly to CODX’s over the last 12 months.
MBOT's Price Growth Rating (65) in the Biotechnology industry is somewhat better than the same rating for CODX (98). This means that MBOT’s stock grew somewhat faster than CODX’s over the last 12 months.
CODX's P/E Growth Rating (6) in the Biotechnology industry is in the same range as MBOT (12). This means that CODX’s stock grew similarly to MBOT’s over the last 12 months.
| CODX | MBOT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 82% | 2 days ago 75% |
| Stochastic ODDS (%) | 2 days ago 80% | 2 days ago 87% |
| Momentum ODDS (%) | 2 days ago 84% | 2 days ago 85% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 89% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 88% | 2 days ago 84% |
| Advances ODDS (%) | about 1 month ago 83% | 8 days ago 73% |
| Declines ODDS (%) | 6 days ago 90% | 2 days ago 86% |
| BollingerBands ODDS (%) | 2 days ago 82% | 2 days ago 79% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CODX’s FA Score shows that 1 FA rating(s) are green while MBOT’s FA Score has 1 green FA rating(s).
- CODX’s FA Score: 1 green, 4 red.
- MBOT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CODX’s TA Score shows that 4 TA indicator(s) are bullish while MBOT’s TA Score has 4 bullish TA indicator(s).
- CODX’s TA Score: 4 bullish, 5 bearish.
- MBOT’s TA Score: 4 bullish, 4 bearish.
Price Growth
CODX (@Medical/Nursing Services) experienced а -24.03% price change this week, while MBOT (@Medical/Nursing Services) price change was -3.67% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
Reported Earning Dates
CODX is expected to report earnings on Nov 12, 2026.
MBOT is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
CODX and
Correlation & Price change
A.I.dvisor tells us that CODX and MBOT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CODX and MBOT's prices will move in lockstep.
| Ticker / NAME | Correlation To CODX | 1D Price Change % | ||
|---|---|---|---|---|
| CODX | 100% | -9.50% | ||
| MBOT - CODX | 31% Poorly correlated | -4.55% | ||
| NVST - CODX | 30% Poorly correlated | -0.50% | ||
| AIMD - CODX | 30% Poorly correlated | -21.78% | ||
| ILMN - CODX | 27% Poorly correlated | -2.66% | ||
| STXS - CODX | 25% Poorly correlated | -9.65% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NVDG | 18.84 | N/A | N/A |
| Leverage Shares 2X Long Nvda Daily ETF | |||
| GXPE | 36.46 | N/A | N/A |
| Global X PureCap MSCI Energy ETF (GXPE) | |||
| JANB | 27.82 | -0.07 | -0.25% |
| Aptus January Buffer ETF (JANB) | |||
| CAIE | 25.84 | -0.08 | -0.31% |
| Calamos Autocallable Income ETF (CAIE) | |||
| RIV | 10.28 | -0.04 | -0.39% |
| RiverNorth Opportunities Fund | |||